Frontiers in Cardiovascular Medicine | Cardiovascular Pharmacology and Drug Discovery

Systematic Review

Published on 15 Aug 2024

Safety and efficacy of aspirin and indobufen in the treatment of coronary heart disease: a systematic review and meta-analysis

in Cardiovascular Pharmacology and Drug Discovery

Xiaochen Zhang
Qiaoyan Yan
Jiao Jiang
Hua Luo
Yu Ren

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1412944

4,122 views
1 citation

Brief Research Report

Published on 08 Aug 2024

Serum concentrations of levosimendan and its metabolites OR-1855 and OR-1896 in cardiac surgery patients with cardiopulmonary bypass

in Cardiovascular Pharmacology and Drug Discovery

Hannah Kipka
Uwe Liebchen
Max Hübner
Georg Höfner
Otto Frey
Klaus T. Wanner
Erich Kilger
Christian Hagl
Roland Tomasi
Hanna Mannell

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1406338

1,187 views

Original Research

Published on 25 Jul 2024

Identification and validation of CCL5 as a key gene in HIV infection and pulmonary arterial hypertension

in Cardiovascular Pharmacology and Drug Discovery

Mengyue Yang
Wen Bi
Zhijie Zhang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1417701

3,297 views

Original Research

Published on 16 Jul 2024

Discontinuation of afterload-reducing drugs decreases left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy

in Cardiovascular Pharmacology and Drug Discovery

Anselm A. Derda
Malin Abelmann
Kristina Sonnenschein
Jan-Thorben Sieweke
Udo Bavendiek
Johann Bauersachs
Thomas Thum
Dominik Berliner

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1403422

2,765 views
1 citation

Review

Published on 08 Jul 2024

The potential therapeutic value of the natural plant compounds matrine and oxymatrine in cardiovascular diseases

in Cardiovascular Pharmacology and Drug Discovery

Shanjiang Chen
Shu Wu
Bin Lin

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1417672

2,536 views
4 citations

Review

Published on 10 Jun 2024

Targeting lymphatic function in cardiovascular-kidney-metabolic syndrome: preclinical methods to analyze lymphatic function and therapeutic opportunities

in Cardiovascular Pharmacology and Drug Discovery

Joseph Wayne M. Fowler
LouJin Song
Kelly Tam
Rachel J. Roth Flach

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1412857

5,274 views
3 citations

Review

Published on 03 Jun 2024

An overview of the treatments for hypertrophic cardiomyopathy

in Cardiovascular Pharmacology and Drug Discovery

Wenna Xu
Fuyu Zhu
Yue Zhang
Peng Li
Yanhui Sheng

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1387596

5,949 views
1 citation

Systematic Review

Published on 30 May 2024

The role of tolvaptan add-on therapy in patients with acute heart failure: a systematic review and network meta-analysis

in Cardiovascular Pharmacology and Drug Discovery

Vireza Pratama
Jordan Budiono
Jarir At Thobari
Bambang Widyantoro
Vita Yanti Anggraeni
Lucia Kris Dinarti

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1367442

3,813 views
3 citations

Systematic Review

Published on 23 May 2024

Effects of different sodium–glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: a network meta-analysis

in Cardiovascular Pharmacology and Drug Discovery

Xiaohua Lan
Huijing Zhu
Yanjie Cao
Yue Hu
Xingman Fan
Kaijie Zhang
Mengdi Wu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1379765

3,324 views
2 citations

Editorial

Published on 20 May 2024

Editorial: Sex differences and cardiovascular therapeutics

in Cardiovascular Pharmacology and Drug Discovery

Fatma Saaoud
Keman Xu
Yifan Lu
Ying Shao
Xiaohua Jiang
Hong Wang
Xiaofeng Yang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1420293

1,414 views

Original Research

Published on 13 May 2024

A real-world pharmacovigilance study of drug-induced QT interval prolongation: analysis of spontaneous reports submitted to FAERS

in Cardiovascular Pharmacology and Drug Discovery

Haowen Tan
Xida Yan
Ying Chen
Guili Huang
Luping Luo
Wenjun Li
Weiwei Lan
Cheng Chen
Xin Xi

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1363382

4,177 views
5 citations

Review

Published on 09 May 2024

The role of lymphatic endothelial cell metabolism in lymphangiogenesis and disease

in Cardiovascular Pharmacology and Drug Discovery

Summer Simeroth
Pengchun Yu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1392816

3,718 views
3 citations

Original Research

Published on 25 Apr 2024

SGLT2 inhibition, plasma proteins, and heart failure: a proteome-wide Mendelian Randomization and colocalization study

in Cardiovascular Pharmacology and Drug Discovery

Jinlan Luo
Lili Shi
Jingrui Liu
Gen Li
Ling Tu
Shuiqing Hu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1371513

4,460 views
1 citation

Review

Published on 23 Apr 2024

Clinical evidence and potential mechanisms of traditional Chinese medicine for refractory heart failure: a literature review and perspectives

in Cardiovascular Pharmacology and Drug Discovery

Liuli Guo
Zhihua Yang
Wenshuai Feng
Yiman Liu
Zhenzhen Li
Pengwei Zhuang
Ming Ren

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1369642

2,003 views

Review

Published on 18 Apr 2024

Natural products in atherosclerosis therapy by targeting PPARs: a review focusing on lipid metabolism and inflammation

in Cardiovascular Pharmacology and Drug Discovery

Yan Zhang
Xue-Ying Zhang
Shan-Rui Shi
Chao-Nan Ma
Yun-Peng Lin
Wen-Gang Song
Shou-Dong Guo

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1372055

4,236 views
12 citations

Review

Published on 19 Mar 2024

Omecamtiv Mecarbil in the treatment of heart failure: the past, the present, and the future

in Cardiovascular Pharmacology and Drug Discovery

Shujing Zhou
Ying Liu
Xufeng Huang
Chuhan Wu
Róbert Pórszász

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1337154

10,776 views
6 citations